Cannabigerol (CBG), the parent cannabinoid of cannabidiol (CBD) and other phytocannabinoids, has only recently come to the fore as a potentially medicinal cannabinoid that is on par with other market favorites – mostly CBD.
Today, consumers are faced with a growing list of exciting and medicinal cannabinoids including CBD, CBN, THC, CBC and now – CBG. This father cannabinoid can reportedly be found in cannabis in small amounts, removing it from the restrictions on synthetic / man-made production. CBG is found in a number of cannabis products, including edibles, tinctures, gums, and a number of other goods.
Dr. José Torradas, a doctor specializing in alternative therapies, told Women’s Health that CBG works on the CB1 and CBD receptors but does not produce highs like tetrahydrocannabinol (THC) and its Delta-8 and Delta-10 variants. Similar to CBD, CBG reportedly has no psychoactive effects, making it much more palatable to a broader market looking to avoid getting high and experiencing paranoia, anxiety, and other side effects commonly associated with THC.
“In terms of how well it connects with CB1 and CB2 receptors, CBG appears to be a lot more effective and direct than CBD,” says Torradas told Womens health. “Similar to CBD, CBG has no psychoactive effects (meaning it doesn’t get you high).”
So what is research saying?
While research on CBG and its purported benefits is still in its infancy, promising studies have been conducted in animals. Preclinical research has shown that CBG can potentially be helpful for inflammatory bowel disease, anxiety disorders, and motor dysfunction such as Parkinson’s disease [1]
“CBG” [research] is still in the early stages, ”Torradas told the magazine. “More robust research and data is needed, and a reduction in extraction costs would help unlock the keys to future adoption of CBG, when these early signs are true.”
Torradas also told the publication that there had been preliminary studies of CBG showing it as a potential antibiotic for MRSA as well.
As with most phytocannabinoid discoveries, there is still a long way to go in terms of medical research before definitive conclusions can be drawn about effectiveness. Until then, users will have to be content with limited medical knowledge and only early results, so the verdict on the effectiveness of CBG is not yet known.
References:
- Navarro, Gemma, et al. “Cannabigerol effect on cannabinoid CB1 and CB2 receptors and on CB1-CB2 heteroreceptor complexes.” Limits in Pharmacology vol. 9 632. 06/21/2018, doi: 10.3389 / fphar.2018.00632
Photo courtesy of Unsplash
The post Is CBG the New CBD? appeared first CBD health and wellness.